• Breast Implant Claims Against Manufacturers

  • Breast Implant Deficiency Notices

  • Breast Implant History

  • Breast Implant Lawyers Can Help

  • Breast Implant Social Workers

  • Breast Implant History

  • The Manufacturers

Breast Implant Blog

  • Dow Corning Breast Implant Litigation Lawyers: Breast Implant Lawyers Accepting Dow Corning Breast Implant ClaimsOur Breat Implant lawyers are reviewing Dow Corning Breast Implant Claims for women implanted with Dow Corning implants prior to June ...

Stories and Sharing

  • Dow Corning Breast Implant Litigation Resources: The Claimants’ Advisory Committee (CAC) is the official committee appointed by the U.S. District Court in the Eastern District of Michigian to represent the interests of women in the Dow Corning Bankr...

Breast Implant News

  • Dow Corning Breast Implant Litigation Resources: The Claimants’ Advisory Committee (CAC) is the official committee appointed by the U.S. District Court in the Eastern District of Michigian to represent the interests of women in the Dow Corning Bankr...

Posts Tagged ‘Arkansas’

Breast Implant Helpline Launches Special Division for Dow Corning Implant Claims

Written by lisaspitzer on . Posted in Breast Implant Blog

Dow corning settlement help is here. if you have filed a Dow Corning Breast Implant Claim and need help with your settlement, a deficiency notice or proof of disease or manufacturer claim contact our Dow Settlement Help Department today at 1 877 522-2123 The complete Dow settlement maize is just too difficult to figure out on your own. let Us help

Settlement Facility – Dow Corning Trust (SF-DCT)

Recent Dow Settlement News:
The Claimants Advisory Committee (CAC) is pleased to announce that after many months of working with the Finance Committee, they have indicated that they will recommend to the District Court that 50 – 100% of Premium Payments be paid to eligible claimants in 2012 or 2014. The Finance Committee will file a motion by the end of June 2011, as required by the Plan, with more details about the recommendation. We do not know anything more about the specifics at this time.
Premium Payments in the Dow Settlement include a possible additional payment on approved Disease claims, possible increased severity payments (for those with approved Disease claims whose symptoms or disease have worsened), and a possible additional payment on approved Rupture claims.
We believe it is likely that Dow Corning will object to making Premium Payments now. We do not have a schedule for a hearing at this time, but the Plan does require that Dow Corning cooperate in an expedited process for review of this issue and to an expedited hearing. We hope to have this issue fully briefed and argued to the District Court by the fall of 2011.
It is important to note that this is the first step to determine whether and when Premium Payments will be paid. The earliest that they could be paid would be in 2012. Please keep your address and other contact information up-to-date with the Settlement Facility so that payments will not be delayed. If you have not completed the Address Verification Form that was mailed to you, please do so immediately. You can obtain a copy from the Settlement Facility by contacting them toll-free at 1-866-874-6099

Relevant deadlines from the June 1, 2004 “Effective Date”

June 2, 1014Explant Claims submission deadline for timely filed claimants in Classes 5, 6.1 and 6.2 (NOTE:  this deadline does NOT apply to NOI claimants or Late Claimants)
June 30, 2019 Disease or Expedited Release Claim submission deadline for all claims in Classes 5, 6.1 and 6.2 (this deadline does NOT apply to Late Claimants)
How long you will have from "NOS"Deadlines from your receipt of "Notification of Status"
NONE SET
Time to provide Acceptable Proof of Manufacturer (POM) for a Dow Corning implant (Class 5).
6 MONTHS
Deadline to cure "Deficiencies" in an Explant Claim (Class 5).
12 MONTHS
Deadline to cure "Deficiencies" in a Disease Claim (Class 5).

Important

You must be a registered claimant in the MDL 926 Revised Settlement Program, and

Already filed a Disease Claim prior to the 12/15/2010 deadline and received a deficiency notice

Submitted additional supporting medical records prior to 12/15/2010 and received a denial in 2011

If you have filed a claim with one of the manufacturer settlement facilities like Dow Trust and need help with proof of manufacturer or a Disease claim call the Breast implant helpline for a breast implant lawyer

Breast Implant, Lawyers Accepting Cases for Dow Corning Breast Implants

Written by lisaspitzer on . Posted in Breast Implant News

Breast Implant Helpline and Breast Implant Lawyers are accepting cases for the Dow Corning Trust Breast Implant Claims. We are helping 1000's of women with unsettled claims or who have rejection letters from other law firms. In light of this this article on new approved silicone breast implants has captured our attention. It reads as follows:

The recent FDA approval of a new breast implant is a reason for all women to rejoice. After years of stagnancy at the FDA in which the newest implants enjoyed by women outside from the U.S. were kept from American women, those needing reconstruction after mastectomy or wanting an augmentation will have more choices. Acting on data rather than pandering to uninformed activists represents an important step towards making the safest and most effective medical devices more widely available to those who need them.

Since the beneficiaries of this approval are the patients, it is perplexing as to why this advance was predominantly covered as a business story. Articles focused on industry economics and stock prices, but absent were stories about women whose lives were improved by these new devices during the rigorous clinical trials that justified their approval, and the many thousands of women who have been awaiting a better implant.

I was interviewed by the Los Angeles Times in 2006 when the FDA approved silicone implants. I explained why they were better for many patients, and I arranged for the reporter to interview several patients. Yet the editors placed this story in the business section, devoid of any content relevant to patients. With destined to develop breast cancer and many women choosing to have a breast augmentation, this is a story of enormous interest that should have been presented in a health or lifestyle section.

The explanation of this enigma goes back to the widespread frivolous breast implant litigation of the early 1990s. Plaintiff attorneys sought to replace the largess of asbestos litigation, and the deep pockets of device manufacturers filled their ravenous appetites and the headlines of newspapers. The FDA's authority to regulate industry but not the practice of medicine further created focus on industry.

This has made the needs of patients secondary. Even a women's rights organization which has opposed all breast implant approval — regardless of specific data — begins its discussion of breast implants on its website by describing the breast implant industry as is providing an implant to reconstruct an amputated breast cultivating insecurity? Is it consistent for a women's rights group to obstruct a woman's right to reconstruct or even augment her own breasts?

Suggesting that surgeons and patients are manipulated by industry is insulting and false. As a surgeon, these manufacturers are my suppliers. Together with my patients, we decide whether they will have a breast implant. Manufacturers spend little on marketing because they acknowledge they cannot affect demand.

The Sientra breast implant approval is a vindication of the scientific method. After two decades of acting in fear of a political backlash, the FDA has fulfilled its mandate to approve a device that has objectively demonstrated its safety and efficacy.

But it is too soon to celebrate. Similar implants made by Allergan and Mentor are yet to be approved, despite data that exceeds that of other available implants. How can that be rationalized by the agency?

Let us hope that reason will triumph

If you are a victim of silicone breast implants or have filed a clim and have a notice of deficiency or a rejection letter fro a law firm we want to hear from you

breast implant Helpline and Breast Implant Lawyers are here for you

Written by lisaspitzer on . Posted in Dow Corning Breast Implant Stories and Sharing

Have you received a recent rejection letter for your Breast Implant Dow Corning claim. Do not fear the Breast Implant Helpline is here to help you.

Breast implant Claim Helpline Can Help You

If you have filed a claim prior to 1994 and have pending status on a DOW Corning Trust Claim we can help you.

Contact the Breast  Implant Claim  Helpline and Speak to a female Medical Social Worker about your breast Implant Claim and  Complications. We will help you locate a female breast Implant Lawyer.  The breast implant Helpline is supporting and assisting  women breast Implant victims nationwide. If you need help with Breast Implant Litigation Cases dealing with the Settlement Facility-Dow Corning Trust (SF-DCT) or the Revised Settlement Plant (RSP) – MDL-926 Claims Office contact the breast Implant lawyers of the Breast Implant Helpline and speak to our female medical social worker today. We are here to assit women with legal issues regarding their Dow claims for implants prior to 1994.

You must have a current claim filed.

History of  Silicone Breast Implants

In 1992, the FDA approved an adjunct study protocol for silicone gel-filled breast implants for reconstruction and revision patients. Three years later in 1995, the major manufacturer of silicone and other implants, Dow Corning Corp. faced 19,000 lawsuits for defective breast implants, forcing the company to file bankruptcy.

About Siicone Breast Implants

Silicone gel-filled breast implants have a silicone outer shell that is filled with silicone gel. They come in different sizes and have either smooth or textured shells. Silicone gel-filled breast implants were approved for breast augmentation in women age 22 or older and for breast reconstruction in women of any age. They are also used in revision surgeries, which correct or improve the result of an original surgery. However what appeared to be beneficial to woman turned out to be one of the biggest disasters in medical implant History. Research has shown that breast implants  have caused woman to suffer life-threatening side effects, including pain and  cancer. Breast implant lawyers are helping victims of breast implant related diseases and complications

Medical Studies have shown that there is probably nothing that you can place in the human body that the body will not attempt to break down. Silicone implants in the body are broken down over time through a lipolysis reaction. Most silicone-filled breast implants leak or rupture within 8 to 15 years.

 Breast Implant Diseases and Complications

The U.S. Food & Drug Administration (FDA) recently warned that both silicone and saline breast implants may be associated with anaplastic large cell lymphoma (ALCL), a rare form of cancer. thousands of women who have had their implants for one or two decades now are seeking medical help for symptoms which resemble arthritis, fibromyalgia, scleroderma, connective tissue disorders, and/or immune dysfunction and seem to be associated with their breast implants.

Additonial Silicone breast Implant Complications Include:

  •     Breast Pain
  •     Upper and Lower Back Pain
  •     dry eyes
  •     joint pain and swelling
  •     myalgias
  •     chronic fatigue
  •     Lupus
  •     numbness and tingling in extremities
  •     photosensitivity
  •     Chemical Sensitivities
  •     Muscle Pain, Stiffness, Unusual Fatigue
  •     Excessive Hair Loss
  •     Achy or Swollen Joints
  •     Extreme fatigue
  •     Skin Rashes
  •     Rheumatoid Arthritis
  •     Polymyositis-Dermatomyositis
  •     Mixed Connective Tissue Disease
  •     Scleroderma
  •     Sjogren's syndrome
  •     Anemia
  •     Sensitivity to Sunlight
  •     Kidney Problems
  •     Fever
  •     Difficulty Swallowing or Breathing

Breast Implant complications may be serious. You must see a physician immediately.

Dangerous Drugs and Medical Devices Harming Women, Womens Health lawyers

Written by lisaspitzer on . Posted in Dow Corning Breast Implant Stories and Sharing

There are so many dangerous drugs and medical device Harming women that the Breast Implant Helpline Has composed an overview for our readers.

Dangerous Drugs and Medical Devices Hurting Women are growing in number .Our Womens health lawyers Take Notice
 

The Female Medical Social Worker at our Womens Health helpline devision is concerned about the huge number of dangerous drugs andmedical devices hurting women

Drugs like bisphosphonates, Yaz, Yasmin,   as well as devices like transvaginal mesh and metal-on-metal hip implants or the Mirena Silicone IUD are marketed toward women. All of these products have had ongoing reports of dangerous risks and injuries to women users with additional warnings being added weekly.

Just this week it was announced that  Birth control settlement: Drug maker Bayer will pay at least $110 million to settle about 500 lawsuits over claims that its Yasmin line of birth control pills caused blood clots, Bloomberg reports. Additional lawsuits are expected. The FDA this week ordered stronger blood clot warnings on the current version of Bayer's pill, Yaz, and similar drugs.

Many of  these products are not being adequately tested for the people they are supposed to be helping. They are being pushed thru on the FDA fast track which approves drugs and devices if the manufacturer can prove it is substantially similiar to a drug or device already approved. This seems tp apply more readily to devices although it can happen with drugs as well.

Although they are made for women, many of these medical products are not designed for women or tested on women before flooding the market. As a result, poorly designed products, many with known complications, are readily available for unsuspecting women.

Another issue is that although serious injuries have been reported by users, the FDA has been slow to act and require a change by manufacturers. In the meantime, product manufacturers have been able to reap financial benefits at the expense of women’s health and safety.

Products Dangerous to Women

Of the growing number of unsafe drugs and medical devices hurting women, certain products have an increasing number of reported risks and injuries.

Birth Control – Yaz, Yasmin

Yaz and Yasmin are two popular birth control medications that contain drospirenone, a manmade hormone that imitates the effects of progesterone. The pills inhibit ovulation and thus prevent pregnancy. When the product was initially made available to the public, it was very popular due to marketing highlighting its ability to clear up acne and lessen other hormonal side effects. Bayer is responsible for the Yaz line of birth control and had slick marketing campaigns while downplaying any evidence that it had a higher percentage of side effects than many other birth control pills. In fact, Bayer has been repeatedly admonished by the FDA for misleading advertisements and, more recently, watered down warnings.

However, label warnings failed to caution women and prescribing doctors of the dangerous risks and potential side effects associated with using the drug. Drospirenone-containing birth control medications, such as Yaz, Yasmin Ocella, Beyaz, Gianvi, Zarah, Loryna and Seyda have an increased risk of side effects such as:

  •     Gallbladder and kidney disease
  •     Blood Clots
  •     Deep Vein Thrombosis (DVT)
  •     Pulmonary Embolism (PE)
  •     Stroke
  •     Cerebrovascular Accidents (CVA)
  •     Heart Attack
  •     Myocardial Infarction
  •     Death

These complications can have long-term health effects and in some cases, even death may be the result.

On April 10, 2012, the FDA announced it was requiring a label change for drugs such as Yaz which contain the chemical drospirenone, warning that the chemical may be associated with a higher risk for blood clots.

According to an April 13, 2012 Bloomberg article, Yaz is still the fourth most popular oral contraceptive, earning Bayer over $1.5 billion in 2010 with prescriptions to millions of women.

Several studies have indicated the blood clots associated with the drug may be linked to an increased risk of stroke, deep vein thrombosis and pulmonary embolism injuries to the lungs.

In 2009, The British Medical Journal published research from Denmark and the Netherlands linking the chemical drospirenone in Yaz to an increased risk of blood clots, a contributing factor for stroke.

In October, 2011, the FDA released a study of more than 800,000 women taking oral contraceptives which showed that those taking drugs like Yaz had a 74% increased risk of developing blood clots.Numerous studies have also been conducted on the safety of birth control pills, like Yaz and Yasmin. In fact, the results of two studies published in the British Journal of Medicine revealed that women taking these types of birth control medications were 2-3 times more likely to develop blood clots than women taking other types of birth control drugs. Drug labels in Europe require this type of warning information and knowledge of the associated dangers is widespread among European doctors..

Transvaginal Mesh

Transvaginal mesh is a medical device used to repair pelvic organ prolapse or damaged tissue from stress urinary incontinence. The mesh product itself was originally used as, or substantially similar to, a hernia product already on the market.

Mesh was not specifically designed for vaginal use. Unlike mesh used to repair hernias, vaginal mesh is used on internal organs that are moving and flexing. When the mesh stays rigid, complications occur, such as metal erosion and infection.

According to a 2011 FDA report, some of the most commonly reported complication risks include:

  •     Pelvic pain
  •     Infections in tissue surrounding the mesh
  •     Bleeding
  •     perforation of the bladder and bowel
  •     Damage to surrounding organs
  •     Erosion or protrusion of the mesh
  •     Pain with intercourse
  •     incessant Urinary tract infections
  •     Vaginal scarring or shrinkage
  •     Recurrent prolapsed

For many women who experience these painful complications, additional corrective surgeries are needed. The growing number of reported injuries has lead to concern by medical professionals, FDA safety alerts to manufactures and ongoing safety investigations.

For more information on the vaginal mesh see vaginalmeshhelpline.com

Bisphosphonate Drugs – Fosamax, Boniva, Actonel

Bisphosphonate drugs, such as Fosamax, Boniva, Actonel, Reclast and Atelvia, are used to treat symptoms of bone degeneration like osteoporosis. Though intended to treat bone disease, ironically, users of the drugs are at risk of bone damage. Namely, bisphosphonate side effects include femur fractures and osteonecrosis of the jaw (damage to the jaw bone). Though drugs like Fosamax, Boniva and Actonel can be used by men or women, older female users most often suffer from painful side effects.

Due to the risk of bone injury, the FDA has required bisphosphonate drug labels to include warnings of the increased risk of fractures. In addition, the agency is continuing to study the effects of long-term bisphosphonate medication use. The drugs are marketed for lifelong use, however, clinical data does not support use after 3-5 years. As a result, medication labels must also include the uncertainty surrounding long-term drug use and its effectiveness.

Metal-on-Metal Hip Implants

Metal-on-metal hip replacement implants are used to replace a diseased hip joint with an artificial joint in order to increase motion, relieve pain and help a patient get back to day-to-day activities. In metal-on-metal devices, both the hip ball and socket are made of metal and intended to be long-lasting. The devices also contain a larger hip ball to provide stability. Unfortunately, the size and nature of the metal-on-metal product, like DePuy’s ASR Acetabular Cup System, also carries an increased risk of dangerous side effects.

Some side effects of metal-on-metal hip replacement devices include:

  •     Blood metal poisoning (metallosis)
  •     Soft tissue damage
  •     Bone loss
  •     Pain
  •     Blood clots
  •     Difficulty walking

In addition, smaller stature women are having more failures and problems with this product. Since the metal on metal hip replacement was designed with a larger ball and cup, it doesn’t work on a smaller framed person. As a result, a disproportionate number of women are being injured. Orthopedic experts believe that inadequate testing and a fatal product flaw have contributed to the serious injuries suffered by patients who have received the metal-on-metal hip implant. Researchers at Bristol University reviewed patient data for approximately 400,000 individuals who underwent hip replacement surgery between 2003 and 2011. Of the 400,000 patients studied, approximately 31,000 were fitted with a metal hip device. The researchers found that among patients with a metal hip, approximately 6.2% required additional revision surgery within five years of undergoing the hip replacement. The revision rate for patients with ceramic-on-ceramic implants was 2.3% and 1.7% for patients whose implants featured a metal-on-plastic construction. The researchers also found that women who had an all-metal hip were up to four times more likely to require corrective surgery versus men who had one of these devices. Specifically, the risk for failure was greatest among women who had a larger femoral head implant. see depuyhipreplacementhelpline.com

FDA Response to Product Injuries

The FDA has taken notice of the disparity in gender-specific testing and gender-specific products. The agency has urged drug and device manufacturers to correct the “historical under representation” of women in clinical trials and studies, as reported by Bloomberg. Certain drugs and devices will react differently when used by women simply because of genetics, such as body frame, mass and hormones, stated the FDA. When manufacturers fail to test products on a proportionate sampling of females, particularly in products intended for use by women, the results are not representative. Nor do safety advocates believe they can adequately account for potential risks and side effects. For these reasons, the FDA released guidelines for manufacturers that addressed how to conduct gender-specific clinical testing, analysis and reporting for product studies.

While further FDA required studies and safety investigations take place, many of these dangerous medical drugs and devices are still available on the market. If you are a woman who has been injured by a medical product, it is important to speak with an attorney experienced in drugs and medical device injury matters. A lawyer can review your case and ensure your legal rights and remedies are being protected.

Breast Implant Helpline in conjunction with Vaginalmeshhelpline.com  Depuyhipreplacementhelpline.com and classactionlawyernetwork.com has launched a joint effort to protect and help women who are victims of dangerous drugs and medical devices. Call our helplines today.

Dow Corning Breast Implant Claims , Adverse Indicent Report

Written by lisaspitzer on . Posted in Breast Implant Blog

MAUDE Adverse Event Report: DOW CORNING CORP.DOW CORNINGSILICONE GEL BREAST IMPLANT. Dow Corning Trust Claims are still active. If you have filed a Dow Corning Claim and Need help call our Dow Corning Claims lawyers today.

DOW CORNING CORP.DOW CORNING SILICONE GEL BREAST IMPLANT

 

Rptr had initial breast implants placed following mastectomy for/ to prevent cancer. Rptr claims she has had the right implant replaced once. She has had two breast surgeries on the left, and four breast surgeries in the right; all beginning with the first implant surgery. Rptr does not have implants in now, does not know if calcium deposits occurred, and states that no biopsies were performed on tissue samples. Medical professionals have not confirmed silicone outside the breast scar tissue capsule. Rptr claims that the left heyer-shulte implant ruptured, and she had one capsular contracture. Rptr claims that the right heyer-shulte implant became a "painful contracture", and that this implant was "traveling from the original site, requiring removal". Rptr states that the dow corining implant was removed "intact", and that she suffered one capsular contracture. Rptr claims to have been diagnosed with the following after implantation: bladder/urinary chronic infections, low blood pressure, carpal tunnel syndrome, anxiety &/or depression, lack of concentration, mood swings, getting lost or confused, balance disturbances/vertigo/dizziness, atypical multiple sclerosis, elevated cholesterol or triglicerides dry eyes, thyroid problems, hashimoto's disease, raynaud's disease, esophagitis, duodenitis &/or gastritis, irritable bowel syndrome, hysterectomy, chronic vaginitis, hypersensitivity or allergies to molds, dust or pollen, unusual chronic infections, connective tissue disease, sjogren's syndrome, chronic swollen lymph nodes, lymphadenopathy under anus, sun sensitive, chronic fatigue syndrome, and clumsiness/drop things.

 

Rptr had initial breast implants placed following mastectomy for/ to prevent cancer. Rptr claims she has had the right implant replaced once. She has had two breast surgeries on the left, and four breast surgeries in the right; all beginning with the first implant surgery. Rptr does not have implants in now, does not know if calcium deposits occurred, and states that no biopsies were performed on tissue samples. Medical professionals have not confirmed silicone outside the breast scar tissue capsule. Rptr claims that the left heyer-shulte implant ruptured, and she had one capsular contracture. Rptr claims that the right heyer-shulte implant became a "painful contracture", and that this implant was "traveling from the original site, requiring removal". Rptr states that the dow corining implant was removed "intact", and that she suffered one capsular contracture. Rptr claims to have been diagnosed with the following after implantation: bladder/urinary chronic infections, low blood pressure, carpal tunnel syndrome, anxiety &/or depression, lack of concentration, mood swings, getting lost or confused, balance disturbances/vertigo/dizziness, atypical multiple sclerosis, elevated cholesterol or triglicerides dry eyes, thyroid problems, hashimoto's disease, raynaud's disease, esophagitis, duodenitis &/or gastritis, irritable bowel syndrome, hysterectomy, chronic vaginitis, hypersensitivity or allergies to molds, dust or pollen, unusual chronic infections, connective tissue disease, sjogren's syndrome, chronic swollen lymph nodes, lymphadenopathy under anus, sun sensitive, chronic fatigue syndrome, and clumsiness/drop things.

If you have a claim filed with Dow Corning Trust and need help with a deficiency notice or other letter from Dow Corning regarding your claim contact the Dow Corning Breast Implant Calim helpline today.

Attention Dow Corning Trust Claimants, Filings Before 1994

Written by lisaspitzer on . Posted in Breast Implant Blog

If you have filed a claim with Dow Corning Trust and need help with the complex settlement system we have lawyers who can help you at no cost to you. To be eligible for help you must be on the Dow Corning Trust settlement list and filed a claim and have a pending Dow Corning Trust Claim. If you have problems with your MDL-926 filing or your Dow Corning Trust Claim contact us immediately for help.

1994, Breast Implants Dow Corning Trust Claims Helpline

 

If you have filed a Breast implant claim prior to 1994 and need help with the Complexities of the Dow Trust or MDL-926 we can help you.

Our Breast Implant team can help with proof of Manufacturer, Disease determinations, and deficiencey notices. We are your source for making sense of a difficult maize of requirements. Our Breast implant lawyers have helped thousands of women. Contact us for help with your settlement claims;

MDL-926 Breast Implant Revised Settlement Program:

The Revised Settlement Program (RSP) permanently closed on 12/15/10. If your diesease claim was received by Claims Office  before the deadline and you receive a deficiency notice you will have one year from the letter date to correct the deficiency.

If you are a registered claimant of the MDL 926 and have filed prior to 12/15/10 and received a deficiency notice contact the Breast Implant Helpline. If yiu have submitted additional supporting documentation and received a denial in 2011 contact the Breast Implant Helpline.

If you are a registered claimant in the MDL 926 Revised Settlement Program, and have the following:

  • Already filed a Disease Claim prior to the 12/15/2010 deadline
  • Received a deficiency notice
  • Submitted additional supporting medical records prior to 12/15/2010
  • Received a denial in 2011

You have the right to appeal the Claims Offices' ruling within 45 days of notification of your denial.

 

Dow Settlement Facility -Dow Corning Trust and Your Silicone Breast Implants

On 09/06/01 The Settlement Facility – Dow Corning Trust (the "SF-DCT")  was  created to administer silicone gel and implant claims against Dow Corning. You may contact the SF-DCT toll-free at 1-866-874-6099 or (713) 874-6099. SF-DCT and the RSP Claims Office are two separate entities. However, this maize can become extremely confusing very quickly. If you do not have a breast implant lawyer to assist you contact the Breast Implant Helpline Today.

The Settlement Facility for the Dow Corning Trust (SF-DCT) is  processing class 5 claims. Class 7 claims have not been completed yet.

11,000 claimants have been approved for either an Expedited Release Payment of $600.00 or a Disease Cash-Out Offer of $3,000.00. Total payments to date from the Class 7 Fund are $15.5 million. The total fund is $57.5 million NPV.

The Settlement Facility is still reviewing Proof of Manufacturer Claims in Class 7 and is expected to complete all Proof of Manufacturer reviews within the next year.

A breast implant Lawyer can help You

  • Help you respond to your deficiency notice
  • Get  help with proof of manufacturer
  • Get help with proof of disease diagnosis
  • Help you with you Dow Corning Trust  and the Dow Corning Trust Settlement Facility requirements and interfacing
  • Help You with any of the Settlement trust office communications
  • Be your ally and confidant  and help you deal with the process of your Breast implant claim
  • Offer support and guidance
IMPORTANT DEADLINE INFORMATION ON NOI SETTLEMENTS
A settlement has been reached between the Claims Advisory Committee and Dow Corning which allows Notice of Intent (NOI) Claimants to have their claims for Explant, Rupture and Expedited Release processed and if, eligible, paid.  If a NOI claimant has already filed an Explant, Rupture or Expedited Release, they do not need to do anything to accept the NOI Settlement.
The SF-DCT has sent out an “Acceptance of NOI Settlement” form to all eligible NOI claimants.  You can also download a copy of this form on the Claimant Advisory Committee’s web site. If you want the SF-DCT to expedite the review and payment of your claim, you will need to complete the “Acceptance of NOI Settlement” form and mail it to the SF-DCT.  When the SF-DCT receives the form, they will review your claim, and if approved, will issue payment in accordance with the Consent Order and the Plan.
Relevant deadlines from the June 1, 2004 “Effective Date”
10 YEARS Deadline to file your Explantation Claim
(For implant removals after 12-31-90)
15 YEARS
Deadline to file your Disease Claim and Increased Severity Claim
How long you will have from "NOS"
Deadlines from your receipt of "Notification of Status"
NONE SET
Time to provide Acceptable Proof of Manufacturer (POM)
for a Dow Corning implant (Class 5)
2 YEARS
Time to provide Acceptable Proof of Manufacturer (POM) for a Bristol, Baxter, Bioplasty, CUI or Mentor implant (Class 7) when submitting a claim under the Silicone Gel Material Claimant Fund.
6 MONTHS
Deadline to cure "Deficiencies" in an Explant Claim.
12 MONTHS
Deadline to cure "Deficiencies" in a Disease

 

News On Breast Surgery, Breast Implant Claim Helpline

Written by lisaspitzer on . Posted in Breast Implant News

Breast-Sparing Surgery Means More Procedures
By Kristina Fiore, Staff Writer, MedPage Today

Published: April 06, 2012

Reviewed by Zalman S. Agus, MD; Emeritus Professor, Perelman School of Medicine at the University of Pennsylvania.

Action Points

    Breast-conserving surgery (BCS) has become a common treatment for patients with ductal carcinoma in situ (DCIS), but the rate of subsequent diagnostic imaging and invasive breast procedures following BCS is not known.
    This study suggests that women with DCIS who choose to preserve their breasts with BCS may be subject to a high rate of subsequent diagnostic imaging and invasive breast procedures and may not be aware of this potential outcome.

Women with ductal carcinoma in situ (DCIS) who opt to preserve the affected breast face continued diagnostic and invasive procedures potentially for years after surgery, researchers found.

Over 10 years, more than 75% of women who underwent breast-conserving surgery subsequently had either a diagnostic mammogram or an invasive procedure in the same breast, Larissa Nekhlyudov, MD, MPH, of Harvard, and colleagues reported online in the Journal of the National Cancer Institute.

Most procedures occurred in the first six months after surgery, but about half of women still had a procedure during those 10 years even when that first half-year was excluded, they reported.

"The fact that women undergoing breast-conserving surgery are likely to have diagnostic and invasive breast procedures in the conserved breast over an extended period of time is important and needs to be included in discussions about treatment options," they wrote.

Breast-conserving surgery is the most common treatment for DCIS, but it's not known how often women who have the procedure have subsequent evaluations and procedures.

So Nekhlyudov and colleagues assessed 2,948 women with DCIS who underwent breast-conserving surgery from 1990 to 2001, and who were followed for up to 10 years.

During that time, 30.8% of the women had diagnostic mammograms to evaluate new symptoms or new abnormalities on a breast exam or on surveillance mammograms.

Most women — 61.5% — also had at least one ipsilateral invasive procedure over the study period, the most common being an excisional biopsy, they found.

Women who had adjuvant radiation had the highest rate of diagnostic mammograms (34.9%) while those on tamoxifen alone had the lowest rate (22.3%). The results were similar for invasive procedures, the researchers said (64.7% and 49.2%, respectively).

Invasive procedures were most common in the first six months: 51.5% of women had them during this time, and these procedures continued at a median annual rate of 3.1%.

Most diagnostic mammograms, on the other hand, occurred during the second year after surgery (11.4%), with 7.3% of women having one in the first six months. The median annual rate was 4.3%.

In cumulative, 10-year incidence estimates, 41% of women had at least one diagnostic mammogram, 65.7% had at least one invasive procedure, and 76.1% had either event.

When excluding events that occurred during the first six months after breast-conserving surgery, 36.4% had at least one diagnostic mammogram, 30.4% had at least one invasive procedure, and 49.5% had either one over 10 years, the researchers said.

They concluded that the frequency of ongoing diagnostic breast evaluations and procedures after surgery should be included in discussions about treatment.

One limitation of the study, they added, is that it potentially underestimates imaging and invasive procedures because women who had a full mastectomy within six months of breast-conserving surgery were excluded. It may also be limited in its generalizability because the data are from only three healthcare delivery systems, they said.

In an accompanying editorial, Joann Elmore, MD, MPH, of the University of Washington in Seattle, and Joshua Fenton, MD, of the University of California Davis in Sacramento, Calif., agreed that these data should be incorporated into the decision-making process about breast-conserving surgery.

"Women who choose to preserve their breasts with breast-conserving surgery may be embarking on a more extended journey than anticipated," they wrote. "Unfortunately, not all women may be aware of this potential outcome when they consider their treatment options."

"Concerns about the substantial risk of subsequent invasive procedures may possibly sway more women to choose initial mastectomy over breast-conserving surgery," they wrote.

The study was supported by grants from the National Cancer Institute.

Neither the researchers nor the editorialists reported any conflicts of interest.

 

Breast Implant Claims Help ,Filings Prior to 1994, Breast Implants Helpline

Written by lisaspitzer on . Posted in Dow Corning Breast Implant Stories and Sharing

If you have filed a Breast implant claim prior to 1994 and need help with the Complexities of the Dow Trust or MDL-926 we can help you.

Our Breast Implant team can help with proof of Manufacturer, Disease determinations, and deficiencey notices. We are your source for making sense of a difficult maize of requirements. Our Breast implant lawyers have helped thousands of women. Contact us for help with your settlement claims;

 Breast Implant Diseases and Complications

The U.S. Food & Drug Administration (FDA) recently warned that both silicone and saline breast implants may be associated with anaplastic large cell lymphoma (ALCL), a rare form of cancer. thousands of women who have had their implants for one or two decades now are seeking medical help for symptoms which resemble arthritis, fibromyalgia, scleroderma, connective tissue disorders, and/or immune dysfunction and seem to be associated with their breast implants.

Additonial Silicone breast Implant Complications Include:

  •     Breast Pain
  •     Upper and Lower Back Pain
  •     dry eyes
  •     joint pain and swelling
  •     myalgias
  •     chronic fatigue
  •     Lupus
  •     numbness and tingling in extremities
  •     photosensitivity
  •     Chemical Sensitivities
  •     Muscle Pain, Stiffness, Unusual Fatigue
  •     Excessive Hair Loss
  •     Achy or Swollen Joints
  •     Extreme fatigue
  •     Skin Rashes
  •     Rheumatoid Arthritis
  •     Polymyositis-Dermatomyositis
  •     Mixed Connective Tissue Disease
  •     Scleroderma
  •     Sjogren's syndrome
  •     Anemia
  •     Sensitivity to Sunlight
  •     Kidney Problems
  •     Fever
  •     Difficulty Swallowing or Breathing

Breast Implant complications may be serious. You must see a physician immediately.

Symptoms of Lupus

  • Fatigue and fever
  • Joint pain, stiffness and swelling
  • Butterfly-shaped rash on the face that covers the cheeks and bridge of the nose
  • Skin lesions that appear or worsen with sun exposure
  • Fingers and toes that turn white or blue when exposed to cold or during stressful periods (Raynaud's phenomenon)
  • Shortness of breath
  • Chest pain
  • Dry eyes
  • Headaches, confusion, memory loss

FDA and Effects of Silicone breast implants  on Children

At this time, it is not known if a small amount of silicone may pass through from the breast implant silicone shell into breast milk during breastfeeding. Although there are currently no established methods for accurately detecting silicone levels in breast milk, a study measuring silicon (one component in silicone) levels did not indicate higher levels in breast milk from women with silicone gel-filled implants when compared to women without implants.
In addition, concerns have been raised regarding potential damaging effects on children born to mothers with implants. Two studies in humans have found no increased risk of birth defects in children born to mothers who have had breast implant surgery. Although low birth weight, was reported in a third study, other factors (for example, lower pre-pregnancy weight) may explain this finding.

Manufacturers Involved in the Settlement Claims

  • Dow Corning
  • Heyer Schulte
  • American Hospital Supply
  • Natural Y
  • Surgitek
  • Replicon
  • Mentor
  • Cui
  • Brystol Meyer Squibb
  • Medical Engineering
  • McGhan Medical
  • 3M/MCGhan
  • Dow Corning
  • Baxter health care
 

Breast Implant Claims

MDL-926 Breast Implant Revised Settlement Program:

The Revised Settlement Program (RSP) permanently closed on 12/15/10. If your diesease claim was received by Claims Office  before the deadline and you receive a deficiency notice you will have one year from the letter date to correct the deficiency.

If you are a registered claimant of the MDL 926 and have filed prior to 12/15/10 and received a deficiency notice contact the Breast Implant Helpline. If yiu have submitted additional supporting documentation and received a denial in 2011 contact the Breast Implant Helpline.

If you are a registered claimant in the MDL 926 Revised Settlement Program, and have the following:

  • Already filed a Disease Claim prior to the 12/15/2010 deadline
  • Received a deficiency notice
  • Submitted additional supporting medical records prior to 12/15/2010
  • Received a denial in 2011

You have the right to appeal the Claims Offices' ruling within 45 days of notification of your denial.

 

Dow Settlement Facility -Dow Corning Trust and Your Silicone Breast Implants

On 09/06/01 The Settlement Facility – Dow Corning Trust (the "SF-DCT")  was  created to administer silicone gel and implant claims against Dow Corning. You may contact the SF-DCT toll-free at 1-866-874-6099 or (713) 874-6099. SF-DCT and the RSP Claims Office are two separate entities. However, this maize can become extremely confusing very quickly. If you do not have a breast implant lawyer to assist you contact the Breast Implant Helpline Today.

The Settlement Facility for the Dow Corning Trust (SF-DCT) is  processing class 5 claims. Class 7 claims have not been completed yet.

11,000 claimants have been approved for either an Expedited Release Payment of $600.00 or a Disease Cash-Out Offer of $3,000.00. Total payments to date from the Class 7 Fund are $15.5 million. The total fund is $57.5 million NPV.

The Settlement Facility is still reviewing Proof of Manufacturer Claims in Class 7 and is expected to complete all Proof of Manufacturer reviews within the next year.

A breast implant Lawyer can help You

  • Help you respond to your deficiency notice
  • Get  help with proof of manufacturer
  • Get help with proof of disease diagnosis
  • Help you with you Dow Corning Trust  and the Dow Corning Trust Settlement Facility requirements and interfacing
  • Help You with any of the Settlement trust office communications
  • Be your ally and confidant  and help you deal with the process of your Breast implant claim
  • Offer support and guidance

Contact the breast implant Helpline Immediately If you need help with your proof of Manufacturer or obtaining medical records  regarding proof of disease from your silicone Breast Implants. The Breast Implant Helpline is here to help you with your Breast Implant claim

 

Silicone Breast Implants and Immune Disease, DOW Claims filed before 1994

Written by lisaspitzer on . Posted in Breast Implant Blog

Silicone breast implants and immune disease.

Division of Plastic and Reconstructive Surgery, University Hospital, Case Western Reserve University, Cleveland, OH.
Abstract

Silicone was originally regarded as inert in the human body. Silicone medical devices have been associated with various complications that may involve an immune reaction to silicone or a silicone organic complex. There have been more than 80 cases reported in the medical literature of a varied systemic autoimmune illness in patients who have had various foreign materials placed in the breast. Controversy exists as to which complications have a cause and effect relationship, and which represent coincidental findings. It is difficult to distinguish between nonspecific local reactions and reactions that have an immunological basis. Approximately 1,000,000 to 2,000,000 women in the United States have had silicone breast implants inserted for reconstruction or augmentation mammaplasty; 28 of those patients have been reported to have developed a systemic autoimmune disease. Data on the 28 reported cases do not in any way prove a causal relationship between breast implants and immune disease. Given the natural incidence of autoimmune diseases, we would expect a coincidental occurrence in the United States of more than 1,000 cases of autoimmune disease in women who had undergone breast implant surgery. Additional information must be obtained to resolve the question. The true incidence of autoimmune disease in patients with implants needs to be determined. A prospective registry of implant patients should be established and comprehensive retrospective information obtained on the implant patient population. Further experimental work is necessary on the bioreactivity of silicone. Patients with implants and autoimmune disease, once identified, must be carefully evaluated by physicians who are experienced in the treatment of autoimmune disease

Mirena Silicone IUD Another Dangerous medical Device Hurting Women

Written by lisaspitzer on . Posted in Dow Corning Breast Implant Stories and Sharing

Mirena Silicone  IUD Implant Helpline, Mirena Implant lawyers

Mirena silicone IUD, Transvaginal mesh, Bladder Sling, Silicone Breast Implants, Yaz, Yasmin all Harming women

The Mirena Silicone IUD is manufactured by Bayer Phamraceuticals. Bayer touted their Mirena IUD as a way to improve romance,a better sex life, energy, and improved good  looks. In December, the Food and Drug Administration sent a letter ordering Bayer to stop making false and misleading claims. The Mirena IUD has shown to have serious side effects and complications. Injury lawyer Network Mirena Lawyers are accepting cases from women injured by the Mirena IUD birth control device. Join the ongoing lawsuit against the manufacturer of these implant devices. Call The Injury Lawyer Network Mirena IUD Helpline and Speak top a female medical social worker about your Mirena IUD implant complications.

If you have experienced sever complications from the Mirena IUD birth control Device call the Mirena IUD Helpline and speak to a female medical social worker about your Mirena IUD and filing a Mirena IUD lawsuit. It is interesting that many women implanted with the Mirena silicone IUD are showing some of the same symptoms as the silicone breast implants. Could this mean there is a chance for silicone toxicity with the Mirena?

 

 Mirena FDA Warning Letter
 

In December 2009, the US FDA issued Bayer Inc. a warning letter over a promotional program it had used to tout Mirena. Working with the social networking site Mom Central, Bayer had created a Mirena direct marketing program that consisted of a series of house parties hosted by members of the Mom Central community. The program, which Bayer said it discontinued in early 2009, was presented in a consumer’s home or other private setting (e.g. private restaurant party) by a representative from Mom Central (a social networking internet site) and a nurse practitioner. Mirena representatives made claims  with phrases like   "look and feel great", "simple ways to reconnect with ourselves and our partners," and "more likely to be more intimate. These calims beyond birth control device were deemed as misrepresentations. Mirena has shown to cause serious complications as well.

Mirena Silicone IUD Implant Side Effects

 Women who have been implanted with the Mirena birth control device have  experienced serious and even debilitating or life-threatening complications. The device may move  from its original position after being inserted, perforating the uterus or embedding itself in the uterus. In both instances, a doctor must locate and surgically remove the device. Mirena may also migrate outside the uterine cavity and cause adhesions or scarring that can lead to infertility. Depending on the damage caused, affected women may require a complete hysterectomy, and more serious complications could result in death. Since its approval, serious Mirena complications have included ectopic pregnancy, intrauterine pregnancy (a pregnancy in the uterus with the IUD in place), group A streptococcal sepsis, pelvic inflammatory disease (PID), embedment of the device in the uterine wall, and perforation of the uterine wall or cervix. Other common Mirena side effects include irregular spotting or bleeding, headaches, ovarian cysts, vaginitis, painful menstruation, pelvic pain, and breast tenderness.

 complications  that have been linked to Mirena birth control Implant include:

  •     Infertility
  •     Menstrual changes
  •     Lower abdominal pain (cramps)
  •     Acne or other skin problems
  •     Back pain
  •     Breast tenderness
  •     Headache
  •     Mood changes
  •     Nausea

More Serious Complications Include:

  •     Inflammation of the membrane that lines the abdominal cavity and internal organs (Peritonitis).
  •     wrongful death
  •     Intestinal perforations or obstruction,
  •     Erosion of adjacent areas such as the vagina,
  •     Embedment in the uterus,
  •     Pelvic Inflammatory Disease,
  •     Abscesses.
  •     Perforation of the uterus,

   Beginning signs of silicone toxicity are beginning to appear  in many of the descriptions on on line discussion groups and forums.

Find a Mirena Birth control device lawyer for your injuries :